This practical course covered outbreak investigation, pandemic planning, recent developments in respiratory pathogen biology and therapy, and focused around two practical scenarios in which participants could gain experience in managing an acute epidemic.
This practical course will cover outbreak investigation, pandemic planning, recent developments in respiratory pathogen biology and therapy, and will focus around two practical scenarios in which participants will gain experience in managing an acute epidemic. Research during an epidemic and ethical aspects will also be covered.
Location:Amsterdam, Netherlands
Organized by:The course is co-organised by ECDC and European Respiratory Society.
ECDC monitors and reports on influenza transmission and virus circulation in Europe on a weekly basis throughout the flu season, in collaboration with WHO Regional Office for Europe, in the report Flu News Europe.
WHO/Europe launched the Flu Awareness Campaign initiative in 2013 as an extension of European Immunization Week. The Campaign aims at increasing uptake of seasonal influenza vaccination in risk groups.
The World Health Organization (WHO) has recommended the composition of the trivalent influenza vaccine for the southern hemisphere winter 2018 influenza season in a report published 28 September 2017.
An ECDC expert opinion concludes that there is clear evidence supporting the use of neuraminidase inhibitors in the treatment and prevention of influenza. Moreover, the current recommendations in European countries on the use of the neuraminidase inhibitors oseltamivir and zanamivir are appropriate and should be applied by prescribing physicians.
Antibiotic resistance is a threat to public health. It compromises the treatment of infected patients, in particular that of the most severely ill patients. Increasingly, intensive care physicians in Europe are confronted with infections caused by bacteria for which limited or no adequate treatment options are available.
Up to 50 million people a year are estimated to have symptomatic influenza in EU/EEA countries and between 15 000 – 70 000 are estimated to die from influenza associated causes.
Since the last update by ECDC in its risk assessment of 11 June 2015, 18 new cases and one death in a previously reported case have been reported by South Korean authorities.
The latest ECDC mosquito maps show new information about the geographical distribution of Aedes albopictus and Aedes aegypti, invasive mosquitoes which can transmit diseases such as dengue and Zika, in Europe.